Request Your Free White Paper Now:

"Mitigating the risks of Zombie Data for commercial pharma: How legacy patient tokenization errors lead to inefficient NPI targeting and low ROI"

Are you wasting budget on misleading patient and prescriber insights?

Zombie Data—fragmented patient records, synthetic data, and unknown data provenance—is distorting commercial pharmaceutical strategies, inflating costs, and degrading targeting precision. Legacy data sources introduce errors that misguide marketing spend and disrupt AI-driven analytics. This white paper exposes the root causes of Zombie Data and reveals how Verified Data ensures compliance, efficiency, and accuracy.

Key insights include:

• The hidden cost of Zombie Data – How fragmented patient tokens and synthetic records inflate market size and lead to wasted marketing dollars.
• Regulatory and compliance risks – Why unverified data sources threaten auditability and FDA adherence.
• How to fix it – Verified Data strategies that ensure precise NPI targeting, trusted AI/ML models, and reduced spend waste.

Don’t let bad data sabotage your commercial strategy. Download the white paper today to uncover how Verified Data protects your brand performance and maximizes ROI.

Offered Free by: HealthVerity
See All Resources from: HealthVerity